Company Statement: Lilly to acquire ImClone Systems in $6.5 billion transaction
****************************************Eli Lilly and Company (NYSE: LLY) and ImClone Systems Inc. (Nasdaq: IMCL) today announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly...To view the full article, register now.
Already a subscriber? Click here to view full article